SG Americas Securities’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Sell
36,943
-21,984
-37% -$68.3K ﹤0.01% 3005
2026
Q1
$134K Sell
58,927
-15,639
-21% -$36K ﹤0.01% 2818
2025
Q4
$209K Buy
74,566
+11,542
+18% +$41.3K ﹤0.01% 2909
2025
Q3
$303K Buy
63,024
+30,104
+91% +$192K ﹤0.01% 2476
2025
Q2
$300K Buy
+32,920
New +$243K ﹤0.01% 2003
2025
Q1
Sell
-10,618
Closed -$139K 3667
2024
Q4
$139K Sell
10,618
-20,882
-66% -$278K ﹤0.01% 2472
2024
Q3
$494K Buy
+31,500
New +$477K ﹤0.01% 1702
2024
Q2
Sell
-37,851
Closed -$1.05M 3184
2024
Q1
$1.05M Buy
37,851
+31,294
+477% +$695K 0.01% 1118
2023
Q4
$126K Sell
6,557
-30,548
-82% -$553K ﹤0.01% 2564
2023
Q3
$600K Buy
+37,105
New +$659K 0.01% 1628
2023
Q2
Sell
-18,076
Closed -$263K 2925
2023
Q1
$263K Buy
+18,076
New +$324K ﹤0.01% 2212
2022
Q4
Sell
-8,831
Closed -$213K 3291
2022
Q3
$213K Sell
8,831
-8,749
-50% -$270K ﹤0.01% 2277
2022
Q2
$553K Buy
+17,580
New +$637K 0.01% 1876
2022
Q1
Sell
-67,512
Closed -$2.94M 3309
2021
Q4
$2.94M Buy
67,512
+11,570
+21% +$454K 0.02% 801
2021
Q3
$1.75M Buy
55,942
+52,734
+1,644% +$2.08M 0.01% 1397
2021
Q2
$136K Sell
3,208
-14,228
-82% -$554K ﹤0.01% 2510
2021
Q1
$655K Buy
17,436
+7,045
+68% +$220K ﹤0.01% 1824
2020
Q4
$281K Sell
10,391
-45,807
-82% -$1.18M ﹤0.01% 2417
2020
Q3
$1.41M Sell
56,198
-51,560
-48% -$752K 0.01% 990
2020
Q2
$821K Buy
107,758
+15,672
+17% +$115K 0.01% 1608
2020
Q1
$843K Buy
92,086
+6,277
+7% +$37.9K 0.01% 1416
2019
Q4
$444K Sell
85,809
-1,729
-2% -$11.1K ﹤0.01% 1876
2019
Q3
$509K Sell
87,538
-14,603
-14% -$65.5K ﹤0.01% 1874
2019
Q2
$327K Sell
102,141
-556,124
-84% -$1.9M ﹤0.01% 2147
2019
Q1
$2.7M Buy
658,265
+561,274
+579% +$3.55M 0.02% 691
2018
Q4
$614K Sell
96,991
-33,809
-26% -$351K 0.01% 1711
2018
Q3
$2.16M Sell
130,800
-2,178
-2% -$37K 0.02% 1108
2018
Q2
$2.22M Buy
132,978
+16,421
+14% +$266K 0.02% 869
2018
Q1
$1.81M Sell
116,557
-17,840
-13% -$318K 0.01% 940
2017
Q4
$2.54M Buy
134,397
+14,694
+12% +$326K 0.02% 730
2017
Q3
$3.5M Sell
119,703
-19,735
-14% -$583K 0.03% 486
2017
Q2
$4.49M Buy
139,438
+40,855
+41% +$1.34M 0.04% 440
2017
Q1
$3.41M Buy
98,583
+8,693
+10% +$310K 0.03% 584
2016
Q4
$3.17M Sell
89,890
-54
-0.1% -$1.82K 0.03% 680
2016
Q3
$3.12M Sell
89,944
-3,968
-4% -$139K 0.03% 505
2016
Q2
$3.51M Buy
93,912
+1,110
+1% +$41.7K 0.02% 527
2016
Q1
$3.75M Buy
92,802
+74,742
+414% +$2.78M 0.03% 505
2015
Q4
$650K Buy
18,060
+14,660
+431% +$530K ﹤0.01% 1426
2015
Q3
$109K Sell
3,400
-7,718
-69% -$263K ﹤0.01% 1821
2015
Q2
$378K Buy
11,118
+6,391
+135% +$215K ﹤0.01% 1624
2015
Q1
$160K Sell
4,727
-1,070
-18% -$37.3K ﹤0.01% 2008
2014
Q4
$204K Sell
5,797
-1,534
-21% -$51.7K ﹤0.01% 2399
2014
Q3
$240K Sell
7,331
-27,208
-79% -$926K ﹤0.01% 1889
2014
Q2
$1.17M Buy
34,539
+11,133
+48% +$381K 0.01% 1277
2014
Q1
$820K Buy
23,406
+18,259
+355% +$644K ﹤0.01% 1221
2013
Q4
$188K Sell
5,147
-32,040
-86% -$1.18M ﹤0.01% 2069
2013
Q3
$1.29M Buy
37,187
+31,238
+525% +$1.09M 0.01% 1156
2013
Q2
$201K Buy
+5,949
New +$197K ﹤0.01% 1732

Other funds holding ACH

SG Americas Securities's ACH Position: Q2 2026 in Review

SG Americas Securities reduced its Accendra Health (ACH) stake by 37% in Q2 2026, selling an estimated $68.3K and leaving 36,943 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3005.

SG Americas Securities first reported a position in ACH in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.49M in Q2 2017. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • SG Americas Securities held 36,943 shares of Accendra Health worth $126K as of Q2 2026.
  • SG Americas Securities sold 21,984 Accendra Health shares in Q2 2026, an estimated $68.3K.
  • Accendra Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3005 holding.
  • SG Americas Securities first reported a position in Accendra Health in Q2 2013 and has held it in 48 quarters since.
  • SG Americas Securities's Accendra Health position peaked at $4.49M in Q2 2017.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.